Mental Health, Addiction Medicine, and Legal Aspects of End-of-Life Care

This conference has been CANCELLED.

Mental Health, Addiction Medicine, and Legal Aspects of End-of-Life Care is organized by Continuing Education, Inc. The symposium is held from Jul 03 - 10, 2020 at Celebrity Solstice, Seattle, Washington, United States of America.

Target Audience:
Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists, Psychologists, Social Workers

Credits:
• 14 AMA PRA Category 1 Credits™
• 14 ACPE Credits
• 14 CE Credits for Psychologists
• 14 ASWB ACE Credits
• 14.0 Contact Hours
• 4 Hours of Pharmacology for NPs

Program Purpose:
Popular Topics in Addiction Medicine Substance use disorders (SUDs) carry significant personal and societal costs. Patients with SUDs have further physical health problems and SUDs hinder the management of other chronic diseases in general medical practice. However, individuals with SUDs are usually not recognized and not treated in comprehensive medical settings. Covering such patients to depart behavioral healthcare setting results in the vast majority not receiving care. The primary care setting is usually the first and often the only association that these patients have with medical providers. SUDs can be recognized and successfully treated by primary care providers without the need for referral to addiction specialists. Providing primary medical care to individuals with SUDs improves their recovery from SUD, improves their overall health, and decreases healthcare costs.

The National Drug Control Strategy states that addiction treatment should be united into mainstream health care, however, graduate and post-graduate medical education is usually insufficient to adequately prepare medical providers to manage SUDs at the level of primary medical specialties. Training of medical professionals utilizing the CME framework can target gaps in knowledge and skills and improve the rates of recognition and treatment of SUDs.

This series of interactive lectures will present participants with the most advanced evidence on the artifices to identify and effectively manage individuals with opioid, tobacco, alcohol, stimulant, sedative-hypnotic, and cannabis-related disorders. Managing individuals with SUDs and co-occurring psychiatric disorders will also be discussed. Presented material will be illustrated with cases from the primary care setting with opportunities for the audience to problem-solve cases and to practice clinical skills. Throughout presentations, we will examine how to achieve the new information and skills in the daily clinical practice of participants to improve patient care.

Topics:
• Addiction as a chronic brain disease
? Identify the nature of abnormal behavior characterizing addiction and how it results in a chronic and relapsing medical/behavioral disorder.
• Screening, evaluation, and diagnosis of substance use problems
? Employ screening tools and techniques needed to address substance use with their patients, influence them to receive treatment, and refer them knowledgeably to specialized addiction treatment when appropriate
• Managing opioid use disorder in the general medical office
? Explain skills to assess and discuss with patient available medications to treat OUD and to initiate pharmacological treatment in the general medicine setting and to counsel patients on overdose prevention
• Managing tobacco and alcohol use disorders
? Advise patients about the benefits of medical treatments for tobacco and alcohol use disorders and effectively use medications to help patients reduce or stop using these substances.
• Safe prescribing of controlled substances in general practice: prescription psychostimulants and sedative-hypnotics
? Perform in their practice procedures for monitoring safety and misuse of prescribed controlled substances and to develop risk minimization strategies for their practices
• Managing cannabis use and cannabis use disorder
? Fulfill a plan to assess and address cannabis use in patients who are treated for other medical and psychiatric disorders.
• Evaluation and treatment of psychiatric problems in patients who use substances
? Promote and execute protocols and obtain skills to recognize and treat psychiatric problems in substance-using substances using behavioral and pharmacological interventions